PMID- 29731855 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200930 IS - 1792-1074 (Print) IS - 1792-1082 (Electronic) IS - 1792-1074 (Linking) VI - 15 IP - 5 DP - 2018 May TI - Auxiliary diagnostic value of p16 amplification combined with the detection of heterozygous and homozygous loss for urothelial carcinoma. PG - 6533-6540 LID - 10.3892/ol.2018.8137 [doi] AB - The present study aimed to investigate the significance of detecting cyclin dependent kinase inhibitor 2A (p16) gene aberrations in the diagnosis of urothelial carcinoma (UC) using fluorescence in situ hybridization (FISH). A total of 77 voided urine specimens from 65 patients with UC and 12 patients with benign urinary disease were recruited into the current study. Under a fluorescence microscope, cells with large and irregular nuclei were assessed for chromosomal aberrations. The positive rate of p16 amplification in UC samples was 32.3% (21/65), which was significantly higher than that in benign urinary disease samples (16.7%, 2/12; P<0.05). Heterozygous and homozygous loss of p16 was identified in 12 (18.5%) and 23 (35.4%) patients with UC, respectively; p16 expression in the remainder of patients was normal. In addition, as tumor stage or grade advanced, the positive rate of p16 aberrations also increased significantly (P<0.05). In conclusion, p16 gene aberrations may serve important roles in the auxiliary diagnosis of UC by FISH and could be utilized to monitor UC progression. FAU - Mao, Xiaopeng AU - Mao X AD - Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China. AD - Department of Urology Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China. FAU - Li, Baimou AU - Li B AD - Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China. AD - Department of Urology Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China. FAU - Liang, Ying AU - Liang Y AD - Department of Nephrology, General Hospital of Guangzhou Military Command of PLA, Guangzhou, Guangdong 510010, P.R. China. FAU - Li, Shuhua AU - Li S AD - Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China. FAU - Zhou, Jianwen AU - Zhou J AD - Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China. FAU - He, Qiong AU - He Q AD - Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China. FAU - Jiang, Neng AU - Jiang N AD - Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China. FAU - Chen, Yangshan AU - Chen Y AD - Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China. FAU - Sun, Yu AU - Sun Y AD - Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China. FAU - Cui, Yongmei AU - Cui Y AD - Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China. FAU - Jiang, Wenting AU - Jiang W AD - Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China. FAU - Wang, Han AU - Wang H AD - Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China. FAU - Wang, Liantang AU - Wang L AD - Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China. FAU - Ke, Zunfu AU - Ke Z AD - Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China. LA - eng PT - Journal Article DEP - 20180301 PL - Greece TA - Oncol Lett JT - Oncology letters JID - 101531236 PMC - PMC5920842 OTO - NOTNLM OT - amplification OT - deletion OT - fluorescence in situ hybridization OT - p16 OT - urothelial carcinoma EDAT- 2018/05/08 06:00 MHDA- 2018/05/08 06:01 PMCR- 2018/03/01 CRDT- 2018/05/08 06:00 PHST- 2017/08/11 00:00 [received] PHST- 2018/01/10 00:00 [accepted] PHST- 2018/05/08 06:00 [entrez] PHST- 2018/05/08 06:00 [pubmed] PHST- 2018/05/08 06:01 [medline] PHST- 2018/03/01 00:00 [pmc-release] AID - OL-0-0-8137 [pii] AID - 10.3892/ol.2018.8137 [doi] PST - ppublish SO - Oncol Lett. 2018 May;15(5):6533-6540. doi: 10.3892/ol.2018.8137. Epub 2018 Mar 1.